Live Breaking News & Updates on Ongoing Phase

Stay updated with breaking news from Ongoing phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Davida Walsey , Patrickm Boland , Pharma Inc , Academic Gi Cancer Consortium , Ongoing Phase , Study Evaluating , Metastatic Colorectal Cancer , Combination Intended , Create Metabolic Synthetic Lethality , Cancers Symposium , Refractory Metastatic Colorectal Cancer , Pacific Time , Private Securities Litigation Reform Act ,

G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference

- Initial Data from the Ongoing Phase 2 Trial in Combination with the Antibody-Drug Conjugate Sacituzumab Govitecan Suggest a Potentially Meaningful Improvement in Overall Survival for Patients. ....

Jack Bailey , Exchange Commission , Therapeutics Inc , Corporate Communications , Research Triangle Park , Ongoing Phase , Antibody Drug Conjugate , Sacituzumab Govitecan , Potentially Meaningful Improvement , Overall Survival , Patients Receiving Trilaciclib , Vial Volume Growth Accelerated , Fourth Quarter , Growth Over Prior Quarter , Triple Negative Breast Cancer , First Quarter , Runway Expected , Healthcare Conference , Chief Executive Officer , Private Securities Litigation Reform Act , Investor Relations ,

Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones

Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , Joseph Ferra , Prnewswire Elevation Oncology Inc , Clinical Development Program To Include Combination Strategy , Elevation Oncology Inc , Program Updates , Elevation Oncology Announces Program Updates , Corporate Communications Investor Relations , Second Pipeline Program , Exchange Commission , Oncology Announces Program Updates , Ongoing Phase , Development Program , Include Combination , Development Candidate Nomination , Strong Financial Position , Chief Executive Officer , Elevation Oncology , Group Limited , Private Securities Litigation Reform Act , Oncology Investor , Corporate Communications ,

Keros Therapeutics (KROS) announces additional data from two ongoing Phase 2 clinical trials of KER-050

Keros Therapeutics (KROS) announces additional data from two ongoing Phase 2 clinical trials of KER-050
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Simon Cooper , Jasbirs Seehra , American Society Of Hematology , Keros Therapeutics Inc , Keros Therapeutics , American Society , Annual Meeting , Chief Medical Officer , Total Symptom , Chief Executive , Clinical Benefit , Findings From , Ongoing Phase , Reduced Iron Overload , Increased Bone Specific Alkaline Phosphatase , Restore Balance , Superfamily Signaling , Treat Myelofibrosis , Mitigate Ruxolitinib Associated , Total Symptom Score ,

Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition

Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Simon Cooper , Jasbirs Seehra , Justin Frantz , American Society Of Hematology , Exchange Commission , Keros Therapeutics Inc , American Society Of Hematology Annual Meeting , Company Quarterly Report On Form , Therapeutics Presents Clinical Data , American Society , Hematology Annual Meeting , Keros Therapeutics , Annual Meeting , Chief Medical Officer , Total Symptom , Chief Executive , Clinical Benefit , Findings From , Ongoing Phase , Reduced Iron Overload , Increased Bone Specific Alkaline Phosphatase , Restore Balance , Superfamily Signaling , Treat Myelofibrosis ,